New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod

Go back to New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
(NASDAQ: VBIO) Delayed: 1.12 -0.07 (5.88%)
Previous Close $1.19    52 Week High $1.84 
Open $1.20    52 Week Low $0.61 
Day High $1.20    P/E N/A 
Day Low $1.10    EPS $0.00 
Volume 201,184